Literature DB >> 6217739

Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy.

B J Maron, J K Wolfson, E Ciró, P Spirito.   

Abstract

Distribution of left ventricular (LV) hypertrophy was assessed by wide-angle, 2-dimensional (2-D) echocardiography in 153 patients with hypertrophic cardiomyopathy and compared with the scalar electrocardiogram in the same patients. The most common electrocardiographic alterations were S-T segment changes and T-wave inversion (61%), LV hypertrophy (47%), abnormal Q waves (25%), and left atrial enlargement (24%). LV hypertrophy on the electrocardiogram was significantly more common in patients with the most extensive distribution of LV hypertrophy on 2-D echocardiogram involving substantial portions of both the ventricular septum and LV free wall (type III; 51 of 69, 74%) than in those with more limited distribution of LV hypertrophy (21 of 84, 25%; p less than 0.001). Most patients with hypertrophic cardiomyopathy and normal electrocardiograms (13 of 23) had localized (type I) hypertrophy, but only 4 had the extensive type III pattern of hypertrophy. Abnormal Q waves were significantly more common in those patients without hypertrophy of the anterior, basal septum (type IV; 15 of 27, 56%) than in those with basal septal hypertrophy (23 of 126, 18%; p less than 0.001); abnormal Q waves were uncommon in extensive type III distribution of hypertrophy (13 of 69, 19%). Thus, although no single electrocardiographic abnormality is characteristic of hypertrophic cardiomyopathy, 2-D echocardiography clarifies the significance of certain electrocardiographic patterns: (1) LV hypertrophy on the electrocardiogram, although present in only about half of the study group, was a relatively sensitive (74%) marker for extensive (type III) LV hypertrophy; (2) abnormal Q waves cannot be explained by ventricular septal hypertrophy alone; and (3) a normal electrocardiogram was most commonly a manifestation of localized LV hypertrophy.

Entities:  

Mesh:

Year:  1983        PMID: 6217739     DOI: 10.1016/s0002-9149(83)80034-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  34 in total

1.  The electrocardiogram as a diagnostic tool for hypertrophic cardiomyopathy: revisited.

Authors:  B J Maron
Journal:  Ann Noninvasive Electrocardiol       Date:  2001-10       Impact factor: 1.468

Review 2.  Athlete"s heart and hypertrophic cardiomyopathy.

Authors:  A Pelliccia
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

Review 3.  The pre-sports cardiovascular evaluation: should it depend on the level of competition, the sport, or the state?

Authors:  Yaniv Bar-Cohen; Michael J Silka
Journal:  Pediatr Cardiol       Date:  2012-02-11       Impact factor: 1.655

4.  Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase.

Authors:  Polina Sysa-Shah; Lars L Sørensen; M Roselle Abraham; Kathleen L Gabrielson
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

Review 5.  Mandatory ECG screening of athletes: is this question now resolved?

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2011-12-01       Impact factor: 11.136

6.  Validity of electrocardiographic criteria for left ventricular hypertrophy in children with pressure- or volume-loaded ventricles: comparison with echocardiographic left ventricular muscle mass.

Authors:  M A Fogel; D R Lieb; M A Seliem
Journal:  Pediatr Cardiol       Date:  1995 Nov-Dec       Impact factor: 1.655

Review 7.  Electrovectorcardiographic diagnosis of left septal fascicular block: anatomic and clinical considerations.

Authors:  Andrés Ricardo Pérez Riera; Celso Ferreira; Celso Ferreira Filho; Adriano Meneghini; Augusto Hiroshi Uchida; Paulo Jorge Moffa; Edgardo Schapachnik; Sergio Dubner; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-04       Impact factor: 1.468

Review 8.  Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment.

Authors:  C van der Lee; M J Kofflard; M L Geleijnse; F J Ten Cate
Journal:  Neth Heart J       Date:  2005-12       Impact factor: 2.380

9.  Hypertrophic cardiomyopathy simulating an infiltrative myocardial disease.

Authors:  A Frustaci; F Loperfido; F Pennestrì
Journal:  Br Heart J       Date:  1985-09

10.  Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study.

Authors:  Deborah H Kwon; Randolph M Setser; Zoran B Popović; Maran Thamilarasan; Srikanth Sola; Paul Schoenhagen; Mario J Garcia; Scott D Flamm; Harry M Lever; Milind Y Desai
Journal:  Int J Cardiovasc Imaging       Date:  2008-01-19       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.